OptimizeRx Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for OptimizeRx Corporation (OPRX) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income-20.11-17.57-11.440.38-2.21-3.140.23
Depreciation & Amortization4.332.402.022.092.081.180.32
Deferred Income Tax1.450.000.000.000.000.000.00
Stock Based Compensation11.4713.7215.755.493.170.000.00
Change in Working Capital0.92-15.553.96-7.19-9.69-1.59-2.27
Change in Accounts Receivable-2.17-8.712.28-6.99-10.670.000.00
Change in Accounts Payable-0.070.200.56-0.010.130.000.00
Change in Other Working Capital3.160.211.96-1.291.140.000.00
Other Operating Activities6.830.2115.72-0.120.142.790.66
Net Cash from Operating Activities4.89-7.2410.650.73-6.31-1.660.79
Investing Activities
Capital Expenditures-0.11-0.87-0.24-0.10-0.071.59-0.03
Acquisitions0.00-82.95-2.000.000.00-8.99-5.60
Purchases of Investments0.00-162.78-55.930.000.000.000.00
Sales/Maturities of Investments0.00218.71-0.16-0.39-0.060.000.00
Other Investing Activities-0.340.000.000.000.000.000.00
Net Cash from Investing Activities-0.45-25.34-58.18-0.49-0.12-10.58-5.69
Financing Activities
Debt Repayment-4.00-1.710.000.000.000.000.00
Common Stock Issued0.000.001.0780.292.4921.308.16
Common Stock Repurchased-0.91-7.52-20.020.000.000.000.00
Other Financing Activities0.000.001.07-6.36-4.390.000.00
Net Cash from Financing Activities-4.9128.22-18.9573.92-1.9022.188.69
Summary
Net Change in Cash-0.47-4.36-66.4774.16-8.349.943.79
Cash at Beginning of Period13.8518.2184.6810.5218.858.915.12
Cash at End of Period13.3813.8518.2184.6810.5218.858.91
Free Cash Flow4.78-8.1110.410.63-6.38-3.250.70
Supplemental Disclosures
Interest Paid6.201.210.000.000.000.000.00
Income Taxes Paid0.160.050.000.000.000.000.00